Search Results - nb2axx

1 Results Sort By:
Rapid Anti-Depressant Response Produced by Low Dose Treatment with Anti-Muscarinic Drugs
Available for licensing are new methods of rapidly treating depression. The drugs currently used to treat depression work by increasing the activity at serotonin, norepinephrine and perhaps dopamine receptors in the CNS. However these drugs are effective in only 60-70% of patients, require 3-4 weeks of treatment before clinical improvement and have...
Published: 10/28/2024   |   Inventor(s): Wayne Drevets
Keywords(s): NB2AXX, NB2DXX, NBXXXX, NXXXXX
Category(s): Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Neurology